Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ear Neoplasms × Remifentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Ear Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093143 2014-03-20

ENDOTANIL

Centre Hospitalier Universitaire de Besancon

Phase 3 Completed

Ear Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡